AzTrials
AzTrials

Fasciitis, PlantarNCT06426667

Effect of Radiofrequency Treatment in Plantar Fasciitis Patients

An observational study of Fasciitis, Plantar, run by Ankara University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

In adults, chronic plantar fasciitis stands as the predominant cause of persistent heel discomfort.Usually, individuals depict a pulsating pain concentrated around the point of origin of the plantar fascia on the calcaneus. Read more about this study

Who is it for?
Ages 18 to 65 years
Conditions the study is for
Fasciitis, Plantar
What is being tested?
posterior tibial nerve radiofrequency and plantar fasciitis radiofrequency
Type of treatment
Surgery or procedure
How many people
108 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Apr 2024to 30 Nov 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients between the ages of 18 and 65 who are scheduled to receive radiofrequency tretament due to plantar fasciitis will be included in the study.

Who may be able to join

  • 18-65 years old,
  • Heel pain for at least 6 months and a diagnosis of plantar fasciitis confirmed by direct radiography and physical examination,
  • Visual analog scale is 4 or more
  • No response to conservative treatment (medical and physical medicine modalities)

Who cannot join

  • History of trauma or calcaneus fracture,
  • Osteoarthritis, Diabetes mellitus, chronic heart disease
  • Presence of pregnancy,
  • Pain due to peripheral neuropathy or ischemia
  • Inability to tolerate injections in the heel area,
  • Allergy to local anesthetics or steroids,
Show all 14Show fewer
  • Presence of an open wound on the side of the foot that the injection will be performed
  • Local or systemic infection at the time of the procedure
  • Previous steroid injection, radiofrequency application or ESWT (electroshock wave) treatment into the heel
  • History of surgical intervention to the heel
  • Presence of any functional limitation in the affected foot
  • Presence of neurological, hepatic and/or metabolic diseases; dermatological infections, seronegative spondyloarthropathy, bleeding diathesis
  • Failure to discontinue anticoagulant or antiaggregant within the specified periods
  • Absence of follow-up throughout the study.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Ankara University

    Ankara, 06230

Other trials in Turkey (Türkiye)

About this study

Official title: Effect of Radiofrequency Treatments on Foot Functionality Index, Patient Satisfaction and Pain Scores in Plantar Fasciitis Patients

In adults, chronic plantar fasciitis stands as the predominant cause of persistent heel discomfort.Usually, individuals depict a pulsating pain concentrated around the point of origin of the plantar fascia on the calcaneus. Numerous randomized and non-randomized studies have demonstrated the effectiveness of radiofrequency as a treatment modality for chronic plantar heel pain.In this study, our objective is to assess the impact of radiofrequency modalities applied to the posterior tibial nerve and/or the calcaneal spur area, guided by ultrasound, on patient satisfaction, pain scores, and functional improvement in individuals with chronic plantar fasciitis

Read the detailed description

Chronic plantar fasciitis is the most common cause of chronic heel pain in adults. Typically, patients describe a throbbing pain localized around the origin of the plantar fascia on the calcaneus. This pain is often most severe when taking the first steps in the morning or rising after sitting. It typically improves with activity but worsens with prolonged activity. The primary aim of heel spur treatment is to alleviate pain and restore function. Surgical interventions are recommended for chronic plantar heel pain resistant to conservative options. However, surgery may be associated with prolonged recovery, and in one study, superiority over conservative treatment was not demonstrated. Radiofrequency has been shown to be an effective treatment method for chronic plantar heel pain in many randomized and non-randomized studies. In many studies, most of these procedures are applied blindly based on anatomical landmarks, with attention drawn in many studies to applications targeting the terminal branches of the posterior tibial nerve or the spur region. Only a few studies have been performed using fluoroscopy and ultrasound guidance. Ultrasound guidance offers several advantages over fluoroscopy and blind landmark techniques, especially in interventional procedures targeting neural and soft tissues. These advantages include the ability to visualize vascular and neural structures, very low risk of vascular-neural injury, absence of radiation exposure, and superiority in cases of anatomical variation. However, a common point in many studies related to plantar fasciitis is that applications are either directed to the spur area or to neural structures leading to the heel region. In this study, we aim to compare the effects of radiofrequency modalities applied to the posterior tibial nerve and/or calcaneal spur area under ultrasound guidance on patient satisfaction, pain scores, and patient functionality in cases of chronic plantar fasciitis (heel spur).

Being tested
posterior tibial nerve radiofrequency, plantar fasciitis radiofrequency
Keywords
Fasciitis, Plantar, Radiofrequency Therapy
Medical subject headings
Fasciitis, Plantar

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • posterior tibial nerve radiofrequencyProcedure or surgery

    pulse radiofrequency at 45 V for 300 seconds at 42 degrees Celsius is applied to the posterior tibial nerve area. During the procedure, the temperature at the electrode tip is kept below 42°C. Following negative aspiration (in the absence of blood), 2 cc of 1% lidocaine + 4 mg dexamethasone is applied to the same area.

  • plantar fasciitis radiofrequencyProcedure or surgery

    the spur area on the calcaneal bone is identified, and sensory and motor stimulations are applied using the RF cannula. If no sensory or motor response is elicited in the area, conventional radiofrequency at 45 V for 60 seconds at 80 degrees Celsius is applied to the spur area after confirming the placement of the RF cannula.

Study groups in NCT06426667
Study groupRoleWhat they receive
posterior tibial nerve radiofrequencyposterior tibial nerve pulsed radiofrequency treatment
Receives: Procedure: posterior tibial nerve radiofrequency
plantar fasciitis radiofrequencycalcaneal spur thermocoagulation radiofrequency treatment
Receives: Procedure: plantar fasciitis radiofrequency
posterior tibial nerve and plantar fasciitis radiofrequencyposterior tibial nerve pulsed radiofrequency and calcaneal spur thermocoagulation radiofrequency treatment
Receives: Procedure: posterior tibial nerve radiofrequency; Procedure: plantar fasciitis radiofrequency

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. pain severity

    pain severity change by using Numeric Rating Scala will be observed before and at 1 week, 1, 3 months after the procedure.

    pain severity change by using Numeric Ratin Scala was observed 3 months after the procedure.The 11-point numerical scale ranges from '0', representing "no pain", to '10', representing extreme pain (e.g., "pain as bad as you can imagine" or "worst pain imaginable").

    Measured: 1 and 3 months

  2. Patient satisfaction after the procedure

    Patients will evaluate their satisfaction after the procedure as "satisfied", "uncertain" or "not satisfied".

    Measured: 1 and 3 months

  3. functionallity

    Functionality of foot will be observed at before the procedure and 1 week, 1, 3 months after the procedure. Foot functionalliy index will be used. Foot function index consists of 23 items with 3 subgroups: pain, disability and activity limitation. To calculate the subscales and total score, the scores of each item are summed, divided by the sum of the maximum scores of the items and multiplied by 100. Higher scores indicate more pain, disability, and activity limitation. The survey score varies between 0-100, and as the score increases, the disability increases.

    Measured: 1 and 3 months

  4. medication use

    number of medication use (nonsteroidal anttinflamatort drugs, opioids, muscle relaxants) wiil be evaluated

    Measured: 1 and 3 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2024
  2. Study start15 Apr 2024
  3. Primary completion30 Jul 2024
  4. Study completion30 Nov 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
108 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06426667
Sponsor's protocol ID
2024/202
Status last verified
May 2024
First submitted
18 May 2024
Last updated
13 Jun 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Latt LD, Jaffe DE, Tang Y, Taljanovic MS. Evaluation and Treatment of Chronic Plantar Fasciitis. Foot Ankle Orthop. 2020 Feb 13;5(1):2473011419896763. doi: 10.1177/2473011419896763. eCollection 2020 Jan.

    PubMed 35097359
  • Li X, Zhang L, Gu S, Sun J, Qin Z, Yue J, Zhong Y, Ding N, Gao R. Comparative effectiveness of extracorporeal shock wave, ultrasound, low-level laser therapy, noninvasive interactive neurostimulation, and pulsed radiofrequency treatment for treating plantar fasciitis: A systematic review and network meta-analysis. Medicine (Baltimore). 2018 Oct;97(43):e12819. doi: 10.1097/MD.0000000000012819.

    PubMed 30412072
  • Wu YT, Chang CY, Chou YC, Yeh CC, Li TY, Chu HY, Chen LC. Ultrasound-Guided Pulsed Radiofrequency Stimulation of Posterior Tibial Nerve: A Potential Novel Intervention for Recalcitrant Plantar Fasciitis. Arch Phys Med Rehabil. 2017 May;98(5):964-970. doi: 10.1016/j.apmr.2017.01.016. Epub 2017 Feb 14.

    PubMed 28209507
  • Orhurhu V, Urits I, Orman S, Viswanath O, Abd-Elsayed A. A Systematic Review of Radiofrequency Treatment of the Ankle for the Management of Chronic Foot and Ankle Pain. Curr Pain Headache Rep. 2019 Jan 19;23(1):4. doi: 10.1007/s11916-019-0745-5.

    PubMed 30661127

Questions about this trial

What is this clinical trial studying?

An observational study of Fasciitis, Plantar, run by Ankara University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 14 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 13 Jun 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

pain severity (time frame: 1 and 3 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06426667, which also lists 4 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jun 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in